Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration
dc.contributor.author | Gabillard, Delphine | |
dc.contributor.author | Lewden, Charlotte | |
dc.contributor.author | Ndoye, Ibra | |
dc.contributor.author | Moh, Raoul | |
dc.contributor.author | Segeral, Olivier | |
dc.contributor.author | Tonwe-Gold, Besigin | |
dc.contributor.author | Etard, Jean-François | |
dc.contributor.author | Pagnaroat, Men | |
dc.contributor.author | Fournier-Nicolle, Isabelle | |
dc.contributor.author | Eholié, Serge | |
dc.contributor.author | Konate, Issouf | |
dc.contributor.author | Minga, Albert | |
dc.contributor.author | Mpoudi-Ngole, Eitel | |
dc.contributor.author | Koulla-Shiro, Sinata | |
dc.contributor.author | Zannou, Djimon Marcel | |
dc.contributor.author | Anglaret, Xavier | |
dc.contributor.author | Laurent, Christian | |
dc.date.accessioned | 2014-11-30T16:11:39Z | |
dc.date.available | 2014-11-30T16:11:39Z | |
dc.date.issued | 2013-04-15 | |
dc.identifier.citation | Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration. 2013, 62 (5):555-61 J. Acquir. Immune Defic. Syndr. | en_GB |
dc.identifier.issn | 1944-7884 | |
dc.identifier.pmid | 23274931 | |
dc.identifier.doi | 10.1097/QAI.0b013e3182821821 | |
dc.identifier.uri | http://hdl.handle.net/10144/336359 | |
dc.description.abstract | In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions. | |
dc.language.iso | en | en |
dc.publisher | Lippincott Williams and Wilkins | en_GB |
dc.rights | Archived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999) | en_GB |
dc.subject | HIV/AIDS | en_GB |
dc.subject.mesh | Acquired Immunodeficiency Syndrome | en_GB |
dc.subject.mesh | Adolescent | en_GB |
dc.subject.mesh | Adult | en_GB |
dc.subject.mesh | Africa South of the Sahara | en_GB |
dc.subject.mesh | Anti-HIV Agents | en_GB |
dc.subject.mesh | Asia | en_GB |
dc.subject.mesh | CD4 Lymphocyte Count | en_GB |
dc.subject.mesh | Cohort Studies | en_GB |
dc.subject.mesh | Female | en_GB |
dc.subject.mesh | HIV Infections | en_GB |
dc.subject.mesh | HIV-1 | en_GB |
dc.subject.mesh | Humans | en_GB |
dc.subject.mesh | Incidence | en_GB |
dc.subject.mesh | Linear Models | en_GB |
dc.subject.mesh | Male | en_GB |
dc.subject.mesh | Young Adult | en_GB |
dc.title | Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration | en |
dc.identifier.journal | Journal of Acquired Immune Deficiency Syndromes (1999) | en_GB |
refterms.dateFOA | 2019-03-04T11:36:54Z | |
html.description.abstract | In resource-limited countries, estimating CD4-specific incidence rates of mortality and morbidity among patients receiving antiretroviral therapy (ART) may help assess the effectiveness of care and treatment programmes, identify program weaknesses, and inform decisions. |